DK1154795T3 - Middel til behandling af diagnosticering af restless legs syndrom - Google Patents

Middel til behandling af diagnosticering af restless legs syndrom

Info

Publication number
DK1154795T3
DK1154795T3 DK99957453T DK99957453T DK1154795T3 DK 1154795 T3 DK1154795 T3 DK 1154795T3 DK 99957453 T DK99957453 T DK 99957453T DK 99957453 T DK99957453 T DK 99957453T DK 1154795 T3 DK1154795 T3 DK 1154795T3
Authority
DK
Denmark
Prior art keywords
cei
sleep
restless legs
legs syndrome
agonist
Prior art date
Application number
DK99957453T
Other languages
Danish (da)
English (en)
Inventor
Jan Hedner
Holger Kraiczi
Original Assignee
Jan Hedner
Holger Kraiczi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Hedner, Holger Kraiczi filed Critical Jan Hedner
Application granted granted Critical
Publication of DK1154795T3 publication Critical patent/DK1154795T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Advance Control (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DK99957453T 1998-11-04 1999-11-03 Middel til behandling af diagnosticering af restless legs syndrom DK1154795T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803760A SE9803760D0 (sv) 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel

Publications (1)

Publication Number Publication Date
DK1154795T3 true DK1154795T3 (da) 2006-01-02

Family

ID=20413169

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99957453T DK1154795T3 (da) 1998-11-04 1999-11-03 Middel til behandling af diagnosticering af restless legs syndrom

Country Status (7)

Country Link
EP (1) EP1154795B1 (fr)
AT (1) ATE302025T1 (fr)
DE (1) DE69926804T2 (fr)
DK (1) DK1154795T3 (fr)
ES (1) ES2251242T3 (fr)
SE (1) SE9803760D0 (fr)
WO (1) WO2000025821A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277384B1 (en) 1997-12-22 2001-08-21 Euro-Celtique S.A. Opioid agonist/antagonist combinations
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
JP4453254B2 (ja) 2001-03-30 2010-04-21 東レ株式会社 レストレス・レッグズ症候群治療薬
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
MXPA04009713A (es) 2002-04-05 2005-01-11 Euro Celtique Sa Preparacion farmaceutica que contiene oxicodona y naloxona.
US6960571B2 (en) * 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
CA2535613A1 (fr) * 2003-08-13 2005-02-24 Janssen Pharmaceutica, N.V. Traitement de troubles du sommeil a l'aide d'inhibiteurs de la cholinesterase
CA2543322A1 (fr) 2003-10-21 2005-05-12 Sention, Inc. Esters de carbamoyle inhibant la cholinesterase et liberant des agents pharmacologiquement actifs
DK1742624T3 (da) * 2004-02-18 2010-03-08 Sepracor Inc Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet
EP1604667A1 (fr) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement des impatiences des membres inférieurs
EP1702558A1 (fr) 2005-02-28 2006-09-20 Euro-Celtique S.A. Procédé et dispositif pour évaluer la fonction de l'activité intestinale
EP1891946A1 (fr) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Administration transmuqueuse de la 2,3-diméthoxy-5-méthyl-6-(10-hydroxydecyl)-1,4-benzoquinone
MX2009008288A (es) 2007-02-02 2009-12-01 Colucid Pharmaceuticals Inc Compuestos que inhiben la colinesterasa.
EP2182938A2 (fr) * 2007-07-18 2010-05-12 Colucid Pharmaceuticals, Inc. Procédés pour favoriser la veille
MY152279A (en) 2009-03-10 2014-09-15 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
EP2251010A1 (fr) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Utilisation de tiabendazole et dérivés correspondants pour la thérapie de conditions neurologiques
US20110200671A1 (en) 2010-02-17 2011-08-18 Sun Pharma Advanced Research Company Ltd. Method of treating a disease condition susceptible to baclofen therapy
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO274596A0 (en) * 1996-10-04 1996-10-31 Armstrong, Stuart Maxwell Method for the treatment of neurological or neuropsychiatric disorders
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms

Also Published As

Publication number Publication date
SE9803760D0 (sv) 1998-11-04
DE69926804D1 (de) 2005-09-22
EP1154795A1 (fr) 2001-11-21
WO2000025821A1 (fr) 2000-05-11
ATE302025T1 (de) 2005-09-15
ES2251242T3 (es) 2006-04-16
DE69926804T2 (de) 2006-06-22
EP1154795B1 (fr) 2005-08-17

Similar Documents

Publication Publication Date Title
DK1154795T3 (da) Middel til behandling af diagnosticering af restless legs syndrom
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
CY1107452T1 (el) Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
DK1742624T3 (da) Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
DE69400799T2 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
IN2005KO00312A (fr)
NO20022442D0 (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
ATE431141T1 (de) Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit
HUP0401501A2 (hu) Érrendszeri gyulladás kezelése vagy megelőzése szterin-felszívódást gátló anyagokat tartalmazó gyógyszerkészítmények alkalmazásával
NO20043013L (no) Tetrahydrokinolin analoger som muskarine agonister
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
SE0004101D0 (sv) New use
DE69822810D1 (de) Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
HUP0001913A2 (hu) Pramipexole alkalmazása állandóan mozgó láb szindróma kezelésére szolgáló gyógyszerkészítmények előállítására
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
NO20075831L (no) Krystallinske faste og amorfe former av (-)- halofenat
DE60121978D1 (de) 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN
HUP0203676A2 (hu) Eljárás és gyógyszerészeti készítmény diabetes kezeléséhez